ArticleBMC public health2026
The hidden burden: a regional study revealing the substantial burden and distinct epidemiology of asymptomatic pulmonary tuberculosis in Southern China.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThe clinical spectrum of pulmonary tuberculosis (PTB) ranges from symptomatic to asymptomatic disease, yet the burden and epidemiology of asymptomatic PTB remain poorly characterized. This study aims to elucidate the prevalence, detection methods, and associated features of asymptomatic PTB in southern China through a large-scale comparative analysis.
methodsWe conducted a regional cross-sectional study using data from China’s Tuberculosis Information Management System (2022–2024). A total of 102,274 PTB patients were classified as symptomatic or asymptomatic according to World Health Organization criteria. Descriptive statistics and χ² tests were used to compare demographics, case detection pathways. A multivariable logistic regression model was performed to examine the factors independently associated with asymptomatic presentation.
resultsAmong all cases, 34.0% (n = 34,741) were asymptomatic. This proportion was consistently higher in the developed Pearl River Delta region than in non-PRD regions. Asymptomatic rates were elevated among younger age groups (15–25 years: 44.5%), migrant populations (39.0%), and high-risk groups (38.3%). Although passive case finding accounted for 97.9% of all cases, active case finding identified a markedly higher proportion of asymptomatic PTB (82.4%). Multivariable analysis revealed that the influence of key factors, such as previous TB history (aOR, 1.75, 95%CI,1.64–1.87) and co-morbidities (aOR, 1.74, 95%CI,1.64–1.84) on symptomatic presentation was significantly modified by regional economic development.
conclusionThis study reveals a substantial, under-ascertained reservoir of asymptomatic PTB in China, which is systematically missed by passive detection strategies. The higher yield of ACF and the identified demographic and regional disparities highlight the urgent need for a strategic shift towards proactive, targeted, and contextually adapted screening interventions to interrupt transmission effectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.